A novel moniliformin derivative as pan-inhibitor of histone deacetylases triggering apoptosis of leukemia cells
New and potent agents that evade multidrug resistance (MDR) and inhibit epigenetic modifications are of great interest in cancer drug development. Here, we describe that a moniliformin derivative (IUPAC name: 3‐(naphthalen‐2‐ylsulfanyl)‐4‐{[(2Z)‐1,3,3‐trimethyl‐2,3‐dihydro‐1H‐indol‐2‐ylidene]methyl}...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
13 July 2021
|
| In: |
Biochemical pharmacology
Year: 2021, Volume: 194, Pages: 1-16 |
| ISSN: | 1873-2968 |
| DOI: | 10.1016/j.bcp.2021.114677 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.bcp.2021.114677 Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S0006295221002902 
|
| Author Notes: | Xiaohua Lu, Ge Yan, Mona Dawood, Sabine M. Klauck, Yoshikazu Sugimoto, Anette Klinger, Edmond Fleischer, Letian Shan, Thomas Efferth |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1817983148 | ||
| 003 | DE-627 | ||
| 005 | 20230426141111.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 221004s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.bcp.2021.114677 |2 doi | |
| 035 | |a (DE-627)1817983148 | ||
| 035 | |a (DE-599)KXP1817983148 | ||
| 035 | |a (OCoLC)1361713995 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 32 |2 sdnb | ||
| 100 | 1 | |a Lu, Xiaohua |d 1991- |e VerfasserIn |0 (DE-588)1269447203 |0 (DE-627)1817990551 |4 aut | |
| 245 | 1 | 2 | |a A novel moniliformin derivative as pan-inhibitor of histone deacetylases triggering apoptosis of leukemia cells |c Xiaohua Lu, Ge Yan, Mona Dawood, Sabine M. Klauck, Yoshikazu Sugimoto, Anette Klinger, Edmond Fleischer, Letian Shan, Thomas Efferth |
| 264 | 1 | |c 13 July 2021 | |
| 300 | |a 16 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 04.10.2022 | ||
| 520 | |a New and potent agents that evade multidrug resistance (MDR) and inhibit epigenetic modifications are of great interest in cancer drug development. Here, we describe that a moniliformin derivative (IUPAC name: 3‐(naphthalen‐2‐ylsulfanyl)‐4‐{[(2Z)‐1,3,3‐trimethyl‐2,3‐dihydro‐1H‐indol‐2‐ylidene]methyl}cyclobut‐3‐ene‐1,2‐dione; code: MCC1381) bypasses P-gp-mediated MDR. Using transcriptomics, we identified a large number of genes significantly regulated in response to MCC1381, which affected the cell cycle and disturbed cellular death and survival. The potential targets of MCC1381 might be histone deacetylases (HDACs) as predicted by SwissTargetPrediction. In silico studies confirmed that MCC1381 presented comparable affinity with HDAC1, 2, 3, 6, 8 and 11. Besides, the inhibition activity of HDACs was dose-dependently inhibited by MCC1381. Particularly, a strong binding affinity was observed between MCC1381 and HDAC6 by microscale thermophoresis analysis. MCC1381 decreased the expression of HDAC6, inversely correlated with the increase of acetylated HDAC6 substrates, acetylation p53 and α-tubulin. Furthermore, MCC1381 arrested the cell cycle at the G2/M phase, induced the generation of reactive oxygen species and collapse of the mitochondrial membrane potential. MCC1381 exhibited in vivo anti-cancer activity in xenografted zebrafish. Collectively, MCC1381 extended cytotoxicity towards P-gp-resistant leukemia cancer cells and may act as a pan-HDACs inhibitor, indicating that MCC1381 is a novel candidate for cancer therapy. | ||
| 650 | 4 | |a Apoptosis | |
| 650 | 4 | |a Histone deacetylases | |
| 650 | 4 | |a Leukemia | |
| 650 | 4 | |a Multidrug resistance | |
| 650 | 4 | |a P-glycoprotein | |
| 650 | 4 | |a Zebrafish | |
| 700 | 1 | |a Yan, Ge |e VerfasserIn |4 aut | |
| 700 | 1 | |a Dawood, Mona |d 1987- |e VerfasserIn |0 (DE-588)1220739774 |0 (DE-627)1737676079 |4 aut | |
| 700 | 1 | |a Klauck, Sabine |e VerfasserIn |0 (DE-588)111181967X |0 (DE-627)865928258 |0 (DE-576)476293006 |4 aut | |
| 700 | 1 | |a Sugimoto, Yoshikazu |e VerfasserIn |4 aut | |
| 700 | 1 | |a Klinger, Anette |d 1970- |e VerfasserIn |0 (DE-588)124477690 |0 (DE-627)363374345 |0 (DE-576)294189904 |4 aut | |
| 700 | 1 | |a Fleischer, Edmond |e VerfasserIn |4 aut | |
| 700 | 1 | |a Shan, Letian |e VerfasserIn |4 aut | |
| 700 | 1 | |a Efferth, Thomas |d 1960- |e VerfasserIn |0 (DE-588)112533116 |0 (DE-627)527709158 |0 (DE-576)167480634 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Biochemical pharmacology |d Amsterdam [u.a.] : Elsevier Science, 1958 |g 194(2021), Artikel-ID 114677, Seite 1-16 |h Online-Ressource |w (DE-627)30631777X |w (DE-600)1496199-4 |w (DE-576)081952929 |x 1873-2968 |7 nnas |a A novel moniliformin derivative as pan-inhibitor of histone deacetylases triggering apoptosis of leukemia cells |
| 773 | 1 | 8 | |g volume:194 |g year:2021 |g elocationid:114677 |g pages:1-16 |g extent:16 |a A novel moniliformin derivative as pan-inhibitor of histone deacetylases triggering apoptosis of leukemia cells |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.bcp.2021.114677 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.sciencedirect.com/science/article/pii/S0006295221002902 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20221004 | ||
| 993 | |a Article | ||
| 994 | |a 2021 | ||
| 998 | |g 111181967X |a Klauck, Sabine |m 111181967X:Klauck, Sabine |d 140000 |e 140000PK111181967X |k 0/140000/ |p 4 | ||
| 999 | |a KXP-PPN1817983148 |e 4194296990 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"relHost":[{"origin":[{"dateIssuedDisp":"1958-","dateIssuedKey":"1958","publisher":"Elsevier Science","publisherPlace":"Amsterdam [u.a.]"}],"id":{"zdb":["1496199-4"],"eki":["30631777X"],"issn":["1873-2968"]},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title":"Biochemical pharmacology","title_sort":"Biochemical pharmacology"}],"pubHistory":["1.1958 -"],"part":{"extent":"16","volume":"194","text":"194(2021), Artikel-ID 114677, Seite 1-16","pages":"1-16","year":"2021"},"note":["Gesehen am 21.02.20"],"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"A novel moniliformin derivative as pan-inhibitor of histone deacetylases triggering apoptosis of leukemia cellsBiochemical pharmacology","language":["eng"],"recId":"30631777X"}],"physDesc":[{"extent":"16 S."}],"name":{"displayForm":["Xiaohua Lu, Ge Yan, Mona Dawood, Sabine M. Klauck, Yoshikazu Sugimoto, Anette Klinger, Edmond Fleischer, Letian Shan, Thomas Efferth"]},"id":{"doi":["10.1016/j.bcp.2021.114677"],"eki":["1817983148"]},"origin":[{"dateIssuedKey":"2021","dateIssuedDisp":"13 July 2021"}],"recId":"1817983148","language":["eng"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Gesehen am 04.10.2022"],"person":[{"role":"aut","display":"Lu, Xiaohua","roleDisplay":"VerfasserIn","given":"Xiaohua","family":"Lu"},{"family":"Yan","given":"Ge","roleDisplay":"VerfasserIn","display":"Yan, Ge","role":"aut"},{"given":"Mona","family":"Dawood","role":"aut","display":"Dawood, Mona","roleDisplay":"VerfasserIn"},{"given":"Sabine","family":"Klauck","role":"aut","roleDisplay":"VerfasserIn","display":"Klauck, Sabine"},{"family":"Sugimoto","given":"Yoshikazu","roleDisplay":"VerfasserIn","display":"Sugimoto, Yoshikazu","role":"aut"},{"display":"Klinger, Anette","roleDisplay":"VerfasserIn","role":"aut","family":"Klinger","given":"Anette"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Fleischer, Edmond","given":"Edmond","family":"Fleischer"},{"given":"Letian","family":"Shan","role":"aut","display":"Shan, Letian","roleDisplay":"VerfasserIn"},{"role":"aut","display":"Efferth, Thomas","roleDisplay":"VerfasserIn","given":"Thomas","family":"Efferth"}],"title":[{"title":"A novel moniliformin derivative as pan-inhibitor of histone deacetylases triggering apoptosis of leukemia cells","title_sort":"novel moniliformin derivative as pan-inhibitor of histone deacetylases triggering apoptosis of leukemia cells"}]} | ||
| SRT | |a LUXIAOHUAYNOVELMONIL1320 | ||